Hrt Financial LP Lipocine Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.89 - $1.85 $21,520 - $44,733
-24,180 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.99 - $1.2 $23,938 - $29,016
24,180 New
24,180 $23,000
Q2 2021

Aug 16, 2021
SELL
$1.17 - $1.59 $16,967 - $23,058
-14,502 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.38 - $2.28 $20,012 - $33,064
14,502 New
14,502 $21,000

About Lipocine Inc.

LPCN Quotes by TradingView
  • Ticker LPCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,510,800
  • Market Cap $434M
  • Description
  • Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...
More about LPCN
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email